Medical Communications

The FDA has authorised Novartis’ Kesimpta (ofatumumab) for treating patients with relapsing forms of multiple sclerosis (MS), it has been …

NICE has moved to recommend Roche’s Polivy (polatuzumab vedotin), when combined with rituximab and bendamustine, for the treatment of diffuse …

AstraZeneca’s Imfinzi (durvalumab) has secured approval in Japan for the treatment of extensive-stage small cell lung cancer when combined with etoposide and …

The top 10 news stories this week again focus on coronavirus vaccines and treatments, as professor Alexander Chuchalin has quit …

It’s good news for Mesoblast as an expert FDA panel gave a glowing recommendation for the approval in the US …

The Philippines is expected to begin large scale human testing of Russia’s controversial ‘Sputnik’ coronavirus vaccine. Rodrigo Duterte, the President …

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …

Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s …

The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that …

At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according …

Nordic Nanovector has announced that Dr Christine Wilkinson Blanc has been appointed as the Chief Medical Officer of the company.

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …

Researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to COVID-19 patients, despite a general lack …

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …

US President Donald Trump has signed an executive order which will direct federal agencies to prioritise buying drugs and drug …